Internal Medicine, Nephrology · Flushing, NY
NPI
1740406206
Since 2007
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
39-16 Prince Street, Unit 355
Flushing, NY, 11354
Phone (718) 886-6882
Groups this clinician bills Medicare through
Medicare paid, 2024
$151K
1,180 services
Medicare patients, 2024
264
Average age 76
Drug cost, 2024
$7.1M
18,883 prescriptions
Company payments, 2025
$20K
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Elizabeth Liang was code 99213 (office e&m - established), 262 times for 141 patients. In total Elizabeth Liang billed 1,180 services in 28 codes, and Medicare paid $151K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-12-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 262 | 141 | $73.77 | $19K |
| 90960 ESRD Related Services (not dialysis) | Office | 166 | 28 | $327.31 | $54K |
| 99214 Office E&M - Established | Office | 100 | 59 | $99.68 | $9,968 |
| 99232 Hospital E&M - Subsequent | Facility | 98 | 25 | $68.25 | $6,688 |
| 90961 ESRD Related Services (not dialysis) | Office | 93 | 33 | $272.25 | $25K |
| 36415 Venipuncture Blood Collection | Office | 65 | 47 | $8.65 | $562 |
| 96372 Injection Administration | Office | 61 | 12 | $12.68 | $773 |
| 99222 Hospital E&M - Initial | Facility | 39 | 23 | $113.54 | $4,428 |
| 81003 Clinical Chemistry | Office | 39 | 39 | $2.20 | $85.8 |
| 82570 Clinical Chemistry | Office | 34 | 34 | $5.08 | $173 |
| 90962 ESRD Related Services (not dialysis) | Office | 31 | 14 | $188.40 | $5,840 |
| 99204 Office E&M - New | Office | 30 | 30 | $130.44 | $3,913 |
| G0420 Face-to-face educational services related to the care of chronic kidney disease; individual, per session, per one hour | Office | 22 | 18 | $94.61 | $2,081 |
| 99233 Hospital E&M - Subsequent | Facility | 20 | 16 | $102.63 | $2,053 |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 14 | 12 | $55.17 | $772 |
By year: 2022 $194K for 1,459 services; 2023 $143K for 1,130 services; 2024 $151K for 1,180 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 65 | 47 | $8.65 | $562 |
| 81003 Clinical Chemistry | 39 | 39 | $2.20 | $85.8 |
| 82570 Clinical Chemistry | 34 | 34 | $5.08 | $173 |
Medicare prescription drug claims, 2024
In 2024, the drug Elizabeth Liang prescribed most often to Medicare patients was Farxiga (Dapagliflozin Propanediol), with 1,509 prescriptions and refills. In total Elizabeth Liang wrote 18,883 Medicare prescriptions that cost $7.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Farxiga Dapagliflozin Propanediol | 1,509 | 1,786 | 263 | $996K |
| Kerendia Finerenone | 1,093 | 1,276 | 178 | $814K |
| Atorvastatin Calcium Generic | 1,075 | 1,356 | 196 | $4,700 |
| Olmesartan Medoxomil Generic | 877 | 1,091 | 153 | $5,274 |
| Jardiance Empagliflozin | 854 | 1,063 | 166 | $625K |
| Losartan Potassium Generic | 726 | 954 | 156 | $3,711 |
| Tamsulosin Hcl Generic | 590 | 770 | 109 | $4,864 |
| Calcitriol Generic | 587 | 751 | 98 | $6,818 |
| Amlodipine Besylate Generic | 551 | 743 | 132 | $2,293 |
| Vascepa Icosapent Ethyl | 477 | 619 | 99 | $207K |
| Nifedipine Er Nifedipine | 426 | 514 | 81 | $4,476 |
| Torsemide Generic | 361 | 476 | 88 | $2,815 |
| Tradjenta Linagliptin | 321 | 395 | 69 | $200K |
| Lokelma Sodium Zirconium Cyclosilicate | 278 | 367 | 60 | $175K |
| Hydralazine Hcl Generic | 264 | 345 | 57 | $1,905 |
Brand drugs: 6,936 claims; generic drugs: 11,785 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Elizabeth Liang $20K ($20K in general payments such as food, travel and fees) from 26 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $12K.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 27 | $12K |
| Lilly USA, LLC LLY | 7 | $3,941 |
| AstraZeneca Pharmaceuticals LP AZN | 17 | $432 |
| Amgen Inc. AMGN | 19 | $418 |
| Akebia Therapeutics Inc AKBA | 8 | $368 |
| Travere Therapeutics, Inc. TVTX | 9 | $315 |
| Calliditas Therapeutics US Inc. | 8 | $313 |
| Ardelyx, Inc. ARDX | 5 | $211 |
| Sumitomo Pharma America, Inc. 4506.T | 7 | $174 |
| ANI Pharmaceuticals, Inc. ANIP | 6 | $172 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.